Share this article on:

Impact of the introduction of a combined Haemophilus B conjugate vaccine and hepatitis B recombinant vaccine on vaccine coverage rates in a large west coast health maintenance organization

Davis, Robert L. M.D., M.P.H.; Coplan, Paul Sc.D.; Mell, Loren B.S.; Black, Steven M.D.; Shinefield, Henry M.D.; Lewis, Edwin M.S.

The Pediatric Infectious Disease Journal: July 2003 - Volume 22 - Issue 7 - p 657-658
doi: 10.1097/01.inf.0000076750.50830.25
Brief Reports

Center for Health Studies Group Health Cooperative Seattle, WA (RLD, PC, LM) Kaiser Permanente Vaccine Study Center Oakland, CA (SB, HS) Division of Epidemiology Merck Vaccine Division Blue Bell, PA (EL)

Accepted for publication April 1, 2003.

Address for reprints: Robert L. Davis, M.D., M.P.H., Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, Suite 1600, Seattle, WA 98195. Fax 206-287-2871; E-mail rdavis@u.washington.edu.

© 2003 Lippincott Williams & Wilkins, Inc.